Table 1.
Demographic information and biochemical immunological index of the study and control groups.
| CRS group (study group, n=82) | Simple deviated nasal septum group (control group, n=21) | P-value | |
|---|---|---|---|
| Median age (years, min–max) | 28, 13–40 | 26, 17–40 | 0.139 |
| Male (n,%) | 57, 69.5 | 18, 85.7 | 0.137 |
| Female (n,%) | 25, 30.5 | 3, 14.3 | 0.137 |
| Abnormal blood lipid (n,%) | 21, 25.6 | 3, 14.3 | 0.389 |
| Deviated nasal septum (n,%) | 76, 92.7 | 21, 100.0 | 0.342 |
| TC (mmol/L) (mean, median, min–max) |
4.95±0.67 4.71, 3.92–6.27 |
4.61±1.01 4.61, 3.01–6.51 |
0.406 |
| TG (mmol/L) (mean, median, min–max) |
1.41±0.69 1.20, 0.71–2.87 |
1.06±0.51 0.95, 0.56–2.38 |
0.18 |
| LDL-C (mmol/L) (mean, median, min–max) |
3.23±0.83 3.01, 1.94–4.41 |
2.65±0.80 2.49, 1.78–4.29 |
0.12 |
| VLDLC (mmol/L) (mean, median, min–max) |
0.73±0.36, 0.71, 0.32–1.43 | 0.6±0.27 0.45, 0.35–1.08 |
0.38 |
| FFA (uq/L) (mean, median, min–max) |
348.8±91.96, 350.5, 498–207 | 367.8±152.95 328.5, 582–153 |
0.74 |
| apoB (g/L) (mean, median, min–max) |
0.99±0.26 0.92, 1.38–0.64 |
0.87±0.28 0.80, 1.39–0.56 |
0.30 |
| Lipoprotein(a) (g/L) (mean, median, min–max) |
148.69±108.95 92.85, 338.6–57.9 |
91.41±71.22 71.8, 279–21.4 |
0.18 |
| IgA (g/L) | 2.21±1.06 | 2.10±1.27 | 0.685 |
| IgG (g/L) | 12.39±4.06 | 11.96±5.33 | 0.686 |
| IgM (g/L) | 1.33±0.61 | 1.12±0.41 | 0.139 |
| Number of positive IgE (n,%) | 29, (35.5) | 6, (28.6) | 0.558 |
| Number of positive sIgE (n,%) | 33, (40.2) | 11, (52.4) | 0.316 |
| ANA | 0.42±0.38 | 0.30±0.14 | 0.20 |
| ASO | 109.32±33.06 | 119.45±40.25 | 0.234 |
| RF | 10.28±4.06 | 10.27±5.11 | 0.992 |
| C3 | 1.02±0.56 | 1.01±0.42 | 0.939 |